Real-world comparison of time to next treatment for patients with high-risk CLL/SLL in first line of treatment

被引：0
|
作者：
Hou, Jing-Zhou
Li, John
Vasudevan, Anupama
Gart, Mike
Choksi, Rushir J.
Blanc, Simon
机构：
[1] Univ Pittsburgh Med Ctr UPMC, Pittsburgh, PA USA
[2] Integra Connect PrecisionQ, W Palm Beach, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19027
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-World Comparison of Time to Next Treatment for Patients with CLL Initiated on First-Line Treatment with Ibrutinib Versus Acalabrutinib
    Jacobs, Ryan
    Lu, Xiaoxiao
    Emond, Bruno
    Morrison, Laura
    Kinkead, Frederic
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    Khan, Wasiulla
    Wu, Linda
    Qureshi, Zaina P.
    Levy, Moshe Yair
    BLOOD, 2022, 140 : 1931 - 1933
  • [2] Real-world treatment switching and sequencing to next line of therapy of zanubrutinib, acalabrutinib, and ibrutinib in CLL/SLL
    Pinilla-Ibarz, Javier
    Xue, Mei
    Wu, Elizabeth
    Esselman, Kaitlyn
    Furnback, Wesley
    Challagulla, Swetha
    Yang, Keri
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Real-World Treatment Switching and Sequencing to Next Line of Therapy of Zanubrutinib, Acalabrutinib, and Ibrutinib in Chronic/Small Lymphocytic Leukemia (CLL/SLL)
    Pinilla-Ibarz, Javier
    Xue, Mei
    Wu, Elizabeth
    Esselman, Kaitlyn
    Furnback, Wesley
    Challagulla, Swetha
    Yang, Keri
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S358 - S359
  • [4] Overall Survival Associated with Real-World Treatment Sequences in Patients with CLL/SLL in the United States
    Rhodes, Joanna M.
    Bhandari, Naleen Raj
    Khanal, Manoj
    He, Dan
    Abhyankar, Sarang
    Pagel, John M.
    Hess, Lisa M.
    Skarbnik, Alan P.
    BLOOD, 2024, 144 : 5114 - 5115
  • [5] Real-world treatment sequencing and healthcare costs among CLL/SLL patients treated with venetoclax
    Rogers, Kerry A.
    Emond, Bruno
    Manceur, Ameur M.
    Kinkead, Frederic
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (08) : 1409 - 1420
  • [6] EVINACUMAB TREATMENT OF CARDIOVASCULAR HIGH-RISK PATIENTS IN A REAL-WORLD SETTING
    Volpi, Laura
    Bobbert, Thomas
    Spira, Dominik
    Mai, Knut
    Kassner, Ursula
    ATHEROSCLEROSIS, 2024, 399
  • [7] Real-World Bleeding Risk, Outcomes and Treatment Patterns of Patients with CLL/SLL Receiving BTKi with or without Prescription Anticoagulants or Antiplatelets
    Gordon, Brittaney-Belle Elizabeth
    Wahlstrom, Svea K.
    Teschemaker, Anna
    Mackey, Rachel H.
    Devincenzo, Diana
    Carabuena, Leslie A.
    Thompson, Samantha L.
    Rosenthal, Ning A.
    Moslehi, Javid J.
    BLOOD, 2024, 144 : 5105 - 5106
  • [8] Real-world treatment patterns in first line and relapsed Chronic Lymphocytic Leukemia (CLL)
    Feinberg, Bruce
    Schenkel, Brad
    McBride, Ali
    Ellis, Lorie
    Radtchenko, Janna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S204 - S205
  • [9] First-line Ibrutinib Treatment is Associated with Longer Time to Next Treatment in a Real-World US Veterans Population
    Huang, Qing
    Ellis, Lorie
    Wang, Li
    Shrestha, Sulena
    Sundaram, Murali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S285 - S285
  • [10] Real-world prognostic testing and treatment patterns in CLL/SLL: results from 1462 patients in the informCLL registry
    Mato, Anthony R.
    Ghosh, Nilanjan
    Sharman, Jeff P.
    Brander, Danielle
    Gutierrez, Meghan
    Huang, Qing
    Wu, Linda H.
    Young, Alex
    Upasani, Sandhya
    Naganuma, Maoko
    Barrientos, Jacqueline C.
    BLOOD ADVANCES, 2023, 7 (17) : 4760 - 4764
12345